نتایج جستجو برای: platinum azidothymidine

تعداد نتایج: 21795  

2016
Nejc Hodnik Claudio Baldizzone George Polymeros Simon Geiger Jan-Philipp Grote Serhiy Cherevko Andrea Mingers Aleksandar Zeradjanin Karl J J Mayrhofer

The recycling of precious metals, for example, platinum, is an essential aspect of sustainability for the modern industry and energy sectors. However, due to its resistance to corrosion, platinum-leaching techniques rely on high reagent consumption and hazardous processes, for example, boiling aqua regia; a mixture of concentrated nitric and hydrochloric acid. Here we demonstrate that complete ...

Journal: :Current Oncology 2007
M. Fung-Kee-Fung T. Oliver L. Elit A. Oza H.W. Hirte P. Bryson

QUESTION What is the optimal chemotherapy treatment for women with recurrent ovarian cancer who have previously received platinum-based chemotherapy? PERSPECTIVES Currently, standard primary therapy for advanced disease involves a combination of maximal cytoreductive surgery and chemotherapy with carboplatin plus paclitaxel or with carboplatin alone. Despite initial high response rates, a lar...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2012
Shannon M McAuliffe Stefanie L Morgan Gregory A Wyant Lieu T Tran Katherine W Muto Yu Sarah Chen Kenneth T Chin Justin C Partridge Barish B Poole Kuang-Hung Cheng John Daggett Kristen Cullen Emily Kantoff Kathleen Hasselbatt Julia Berkowitz Michael G Muto Ross S Berkowitz Jon C Aster Ursula A Matulonis Daniela M Dinulescu

Chemoresistance to platinum therapy is a major obstacle that needs to be overcome in the treatment of ovarian cancer patients. The high rates and patterns of therapeutic failure seen in patients are consistent with a steady accumulation of drug-resistant cancer stem cells (CSCs). This study demonstrates that the Notch signaling pathway and Notch3 in particular are critical for the regulation of...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1997
E Gamelin A L Bouil M Boisdron-Celle A Turcant R Delva A Cailleux A Krikorian S Brienza E Cvitkovic J Robert F Larra P Allain

The cumulative pharmacokinetic pattern of oxaliplatin, a new diamminecyclohexane platinum derivative, was studied in patients with metastatic colorectal cancer. Oxaliplatin was administered by i. v. infusion (130 mg/m2) over 2 h every 3 weeks, and 5-fluorouracil and leucovorin were administered weekly. A very sensitive method, inductively coupled plasma-mass spectrometry, allowed for the determ...

Journal: :Environmental Health Perspectives 1975
A F LeRoy

Platinum-metal oxidation catalysts are to be introduced in exhaust systems of many 1975 model-year automobiles in the U.S. to meet Clean Air Act standards. Small quantities of finely divided catalyst have been found issuing from prototype systems; platinum and palladium compounds may be found also. Although platinum exhibits a remarkable resistance to oxidation and chemical attack, it reacts ch...

2014
Gerhard Hamilton

In attempts to develop an orally applicable platinum-based drug, platinum(IV) drugs which exhibit higher in vivo stability compared to the platinum(II) drug cisplatin were formulated. The first such chemotherapeutic agent, namely satraplatin, failed to receive approval. In the present work, we checked the initial cellular stress response of the chemosensitive NCI-H526 small cell lung cancer (SC...

Journal: :Biomedical reports 2016
Tetsuya Oguri Eiji Kunii Satoshi Fukuda Kazuki Sone Takehiro Uemura Osamu Takakuwa Yoshihiro Kanemitsu Hirotsugu Ohkubo Masaya Takemura Ken Maeno Yutaka Ito Akio Niimi

Organic cation transporters (OCTs) of the solute carrier family 22 have a critical role in the cellular uptake of anticancer platinum drugs. Recently, we found that a decreased OCT6 expression is associated with a reduced intracellular uptake of cisplatin (CDDP), and concomitant resistance to CDDP. In the present study, we examined whether OCTs directly confer resistance to another platinum dru...

Journal: :Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2011
Mark Murphy Britta Stordal

BACKGROUND Platinum-based chemotherapy is the standard of care for ovarian cancer and non-small cell lung cancer (NSCLC). However, resistance to platinum agents invariably develops. Targeted therapies, such as tyrosine kinase inhibitors (TKIs), have great potential here as they exert their anti-tumour effect via alternative mechanisms to platinum-based drugs and as such may remain unaffected by...

Journal: :Cancer research 1992
L R Kelland P Mistry G Abel S Y Loh C F O'Neill B A Murrer K R Harrap

Acquired resistance to cisplatin has been generated in vitro in two human ovarian carcinoma cell lines: 41M, established from a previously untreated patient; and CH1, from a patient previously treated with cisplatin and cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) (carboplatin). In neither cell line with acquired resistance did intracellular detoxification (via increased glutathione o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید